Sign in
To Treat or Not to Treat: Are We Sacrificing Treatment Outcomes by Allowing Diabetic Retinopathy (DR) to Enter the Proliferative Stage?
Michael J. Elman, MD
Annual Meeting Talks
2018
Fluorescein Angiography Findings Post-intravitreal Bevacizumab for ROP: Can It Predict the Late-Onset Risk of Recurrence?
Swati Agarwal-Sinha, MD, FASRS
Controlling Uveitic Recurrences: Results From a Phase 3 Study of 0.18 mg Fluocinolone Acetonide Insert (FAi) in Noninfectious Posterior Uveitis
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Category: Age-Related Macular Degeneration